Emphysema Market Highlights
The global emphysema market is expected to grow UDS 19.83 billion at a CAGR of 4.64% during the forecast period 2024 to 2032.
Emphysema is a chronic obstructive pulmonary disease that affects millions of people worldwide. It is a progressive disease that causes damage to the air sacs in the lungs, leading to difficulty in breathing. With no cure currently available, the emphysema market is driven by the demand for effective treatment options to manage symptoms and improve the quality of life for patients.
Factors such as the increasing prevalence of the chronic obstructive pulmonary disease and the rising therapeutics’ demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic technologies boost the market. However, low awareness and lack of healthcare services in the middle- and low-income countries are estimated to restrain the market growth during the projected period.
Segmentation
The global emphysema market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into centrilobular and panlobular emphysema.
On the basis of diagnosis, the market is segmented into imaging tests, lung function tests, and others. The imaging test is further segmented into chest X-ray and CT scan. On the basis of treatment, the market is segmented into medications, therapy, and surgery. Medications are further segmented into smoking cessation drugs, bronchodilators, inhaled steroids, antibiotics, and leukotriene modifiers. Therapy is further segmented into pulmonary rehabilitation, nutrition therapy, gene therapy, and supplemental oxygen. Surgery is further segmented into lung volume reduction surgery, lung transplant, and bullectomy. On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.
Regional Analysis
The Americas dominates the global emphysema market owing to the rising prevalence of the chronic obstructive pulmonary disease and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and the presence of key players within the regional boundaries provide a favorable background for the market growth. Europe is second in the global emphysema market. Factors such as increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region. Asia Pacific is estimated to be the fastest growing market for emphysema. This can be attributed to the presence of developing economies such as India and China and huge patient population. Moreover, rising healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region. On the other hand, the Middle East and Africa has the least share in the global emphysema market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region.
Key Players
Some of the top key emphysema market players are Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc. and others.
In conclusion, the emphysema market research report provides a comprehensive analysis of the market landscape, including key trends, drivers, challenges, and opportunities. The report highlights the major players in the market and their product offerings, financial performance, and strategic initiatives. The report also provides a geographical analysis of the market, including the major regions and their growth prospects. The report is a valuable tool for investors, researchers, and healthcare professionals to gain insights into the emphysema market and make informed decisions.
Related Report:
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian